Increased serum methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes.

被引：0
|
作者：
Kilhovd, BK
Giardino, I
Torjesen, PA
Birkeland, KI
Thornalley, PJ
Brownlee, M
Hanssen, KF
机构：
来源：
DIABETOLOGIA | 2000年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
210
引用
收藏
页码：A53 / A53
页数：1
相关论文
共 50 条
  • [1] Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes
    Kilhovd, BK
    Giardino, I
    Torjesen, PA
    Birkeland, KI
    Berg, TJ
    Thornalley, PJ
    Brownlee, M
    Hanssen, KF
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (02): : 163 - 167
  • [2] Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus
    Fosmark, DS
    Torjesen, PA
    Kilhovd, BK
    Berg, TJ
    Sandvik, L
    Hanssen, KF
    Agardh, CD
    Agardh, E
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (02): : 232 - 236
  • [3] The AGE methylglyoxal-derived hydroimidazolone and early signs of atherosclerosis in childhood diabetes
    Heier, M.
    Margeirsdottir, H.
    Torjesen, P. A.
    Seljeflot, I.
    Stensth, K.
    Gaarder, M.
    Brunborg, C.
    Hanssen, K. F.
    Dahl-Jorgensen, K.
    DIABETOLOGIA, 2013, 56 : S541 - S541
  • [4] Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women
    Kilhovd, Bente K.
    Juutilainen, Auni
    Lehto, Seppo
    Roennmaa, Tapani
    Torjesen, Peter A.
    Hanssen, Kristian F.
    Laakso, Markku
    ATHEROSCLEROSIS, 2009, 205 (02) : 590 - 594
  • [5] Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone, is elevated in young, complication-free patients with Type 1 diabetes
    Han, Y.
    Randell, E.
    Vasdev, S.
    Gill, V.
    Curran, M.
    Newhook, L.
    Grant, M.
    Hagerty, D.
    Schneider, C.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A174 - A174
  • [6] Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes
    Han, Yingchun
    Randell, Edward
    Vasdev, Sudesh
    Gill, Vicki
    Curran, Matthew
    Newhook, Leigh Anne
    Grant, Marie
    Hagerty, Donna
    Schneider, Celine
    CLINICAL BIOCHEMISTRY, 2009, 42 (7-8) : 562 - 569
  • [7] High serum levels of methylglyoxal-derived hydroimidazolone predict increased cardiovascular mortality in non-diabetic women, but not in diabetic subjects
    Kithovd, B. K.
    Juutilainen, A.
    Lehto, S.
    Ronnemaa, T.
    Torjesen, P.
    Hanssen, K.
    Laakso, M.
    DIABETOLOGIA, 2008, 51 : S523 - S523
  • [8] Serum levels of hydroimidazolone are increased in retinopathy of Type 2 diabetes
    Fosmark, DS
    Torjesen, PA
    Kilhovd, B
    Berg, TJ
    Sandvik, L
    Hanssen, KF
    Agardh, CD
    Agardh, E
    DIABETOLOGIA, 2004, 47 : A451 - A452
  • [9] Ascorbic acid oxidation contributes to methylglyoxal-derived hydroimidazolone formation in aged lens
    Fan, Xingjun
    Wang, Benlian
    Sell, David
    Wesson, Daniel
    Monnier, Vincent M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [10] Serum Levels of Protein-Bound Methylglyoxal-Derived Hydroimidazolone-1 are Independently Correlated with Asymmetric Dimethylarginine
    Tahara, Nobuhiro
    Kojima, Ruchia
    Yoshida, Risa
    Bekki, Munehisa
    Sugiyama, Yoichi
    Tahara, Atsuko
    Maeda, Shoko
    Honda, Akihiro
    Igata, Sachiyo
    Nakamura, Tomohisa
    Sun, Jiahui
    Matsui, Takanori
    Fukumoto, Yoshihiro
    Matsui, Toshiro
    Yamagishi, Sho-Ichi
    REJUVENATION RESEARCH, 2019, 22 (05) : 431 - 438
12345